Document
IPR2022-00215, No. 10 Notice refund approved - Notice refund approved (P.T.A.B. Mar. 22, 2022)
Cite Document
IPR2022-00215, No. 10 Notice refund approved - Notice refund approved (P.T.A.B. Mar. 22, 2022)
+ More Snippets
Document
IPR2022-00215, No. 8 Termination Decision Pre DI settlement - Termination Decision Settlement Prior to Institution of Trial (P.T.A.B. Mar. 14, 2022)
Cite Document
IPR2022-00215, No. 8 Termination Decision Pre DI settlement - Termination Decision Settlement Prior to Institution of Trial (P.T.A.B. Mar. 14, 2022)
+ More Snippets
Document
Amarin Pharma, Inc. et al v. Health Net, LLC, 1:20-cv-01630, No. 123 (D.Del. Jun. 10, 2022)
Cite Document
Amarin Pharma, Inc. et al v. Health Net, LLC, 1:20-cv-01630, No. 123 (D.Del. Jun. 10, 2022)
+ More Snippets
Document
IPR2022-00215, No. 3 Notice Notice filing date accorded - Notice Notice filing date accorded (P.T.A.B. Dec. 14, 2021)
Cite Document
IPR2022-00215, No. 3 Notice Notice filing date accorded - Notice Notice filing date accorded (P.T.A.B. Dec. 14, 2021)
+ More Snippets
Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc., et al., 1:20-cv-01630, No. 85 (D.Del. Oct. 20, 2021)
Cite Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc., et al., 1:20-cv-01630, No. 85 (D.Del. Oct. 20, 2021)
+ More Snippets
Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc. et al, 1:20-cv-01630, No. 82 (D.Del. Oct. 4, 2021)
Cite Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc. et al, 1:20-cv-01630, No. 82 (D.Del. Oct. 4, 2021)
+ More Snippets
Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc. et al, 1:20-cv-01630, No. 17 (D.Del. Jan. 25, 2021)
Cite Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc. et al, 1:20-cv-01630, No. 17 (D.Del. Jan. 25, 2021)
+ More Snippets
Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc. et al, 1:20-cv-01630, No. 1 (D.Del. Nov. 30, 2020)
Cite Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc. et al, 1:20-cv-01630, No. 1 (D.Del. Nov. 30, 2020)
+ More Snippets
Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc., et al., 1:20-cv-01630, No. 156-2 (D.Del. Sep. 20, 2023)
Cite Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc., et al., 1:20-cv-01630, No. 156-2 (D.Del. Sep. 20, 2023)
+ More Snippets
Document
IPR2022-00215, No. 6 Motion - Joint Request That Agreement Be Treated As Business Confidential Information And Kept Separate Under 35 USC �� 317b (P.T.A.B. Mar. 10, 2022)
Cite Document
IPR2022-00215, No. 6 Motion - Joint Request That Agreement Be Treated As Business Confidential Information And Kept Separate Under 35 USC �� 317b (P.T.A.B. Mar. 10, 2022)
+ More Snippets
Document
IPR2022-00215, No. 7 Motion - Joint Motion To Terminate (P.T.A.B. Mar. 10, 2022)
Cite Document
IPR2022-00215, No. 7 Motion - Joint Motion To Terminate (P.T.A.B. Mar. 10, 2022)
+ More Snippets
Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc., et al., 1:20-cv-01630, No. 12 (D.Del. Jan. 4, 2021)
Cite Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc., et al., 1:20-cv-01630, No. 12 (D.Del. Jan. 4, 2021)
+ More Snippets
Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc. et al, 1:20-cv-01630, No. 4 (D.Del. Nov. 30, 2020)
Cite Document
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc. et al, 1:20-cv-01630, No. 4 (D.Del. Nov. 30, 2020)
+ More Snippets
Document
IPR2022-00215, No. 2 Petition - IPR Petition 077 (P.T.A.B. Nov. 30, 2021)
Cite Document
IPR2022-00215, No. 2 Petition - IPR Petition 077 (P.T.A.B. Nov. 30, 2021)
+ More Snippets
Document
IPR2022-00215, No. 9 Refund Request - Petitioners Request For Refund Of Post Institution Fees (P.T.A.B. Mar. 15, 2022)
Cite Document
IPR2022-00215, No. 9 Refund Request - Petitioners Request For Refund Of Post Institution Fees (P.T.A.B. Mar. 15, 2022)
+ More Snippets